Global Transcranial Magnetic Stimulation (TMS) Devices Market Growth 2025-2031

The global Transcranial Magnetic Stimulation (TMS) Devices market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

Transcranial Magnetic Stimulation (TMS) Devices are medical devices that generate magnetic field pulses to stimulate brain neuron activity in specific areas of the head. It is a non-invasive treatment that modulates and affects the function of neural networks in the brain.

The TMS device consists of an electromagnetic coil that is placed near the patient"s head. The device generates strong magnetic field pulses that penetrate the skull and reach the cerebral cortex. Pulses of magnetic fields can generate electrical currents in targeted areas, activating or inhibiting neuronal activity. By controlling the parameters of stimulation, such as frequency, intensity, and location, the brain"s neural circuits can be directionally adjusted.

TMS devices are commonly used to treat neuropsychiatric disorders such as depression, anxiety, and schizophrenia. It is considered a relatively safe and non-invasive treatment option, with fewer side effects than traditional drug treatments. TMS may improve symptoms by modulating activity in brain regions and have long-term effects on the connectivity and function of neural networks.

In addition to clinical treatments, TMS devices are also used in research to explore the mechanisms of brain function, neuroplasticity, and related diseases. It can help scientists gain insights into how the brain works and provide new ideas and methods for disease treatment and recovery.

United States market for Transcranial Magnetic Stimulation (TMS) Devices is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Transcranial Magnetic Stimulation (TMS) Devices is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Transcranial Magnetic Stimulation (TMS) Devices is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Transcranial Magnetic Stimulation (TMS) Devices players cover Brainsway, Magstim, Neurosoft, Yiruide, Neuronetics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Transcranial Magnetic Stimulation (TMS) Devices Industry Forecast” looks at past sales and reviews total world Transcranial Magnetic Stimulation (TMS) Devices sales in 2024, providing a comprehensive analysis by region and market sector of projected Transcranial Magnetic Stimulation (TMS) Devices sales for 2025 through 2031. With Transcranial Magnetic Stimulation (TMS) Devices sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Transcranial Magnetic Stimulation (TMS) Devices industry.

This Insight Report provides a comprehensive analysis of the global Transcranial Magnetic Stimulation (TMS) Devices landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Transcranial Magnetic Stimulation (TMS) Devices portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Transcranial Magnetic Stimulation (TMS) Devices market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Transcranial Magnetic Stimulation (TMS) Devices and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Transcranial Magnetic Stimulation (TMS) Devices.

This report presents a comprehensive overview, market shares, and growth opportunities of Transcranial Magnetic Stimulation (TMS) Devices market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Single Pulse
Repetitive Pulse

Segmentation by Application:
Depression
Schizophrenia
Neurological Disease
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Brainsway
Magstim
Neurosoft
Yiruide
Neuronetics
MagVenture
eNeura
Remed
Nexstim
MAG & More
Shenzhen Yingchi Technology
PsyTech
VISHEE
Sichuan Junjian Wanfeng Medical Devices

Key Questions Addressed in this Report

What is the 10-year outlook for the global Transcranial Magnetic Stimulation (TMS) Devices market?

What factors are driving Transcranial Magnetic Stimulation (TMS) Devices market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Transcranial Magnetic Stimulation (TMS) Devices market opportunities vary by end market size?

How does Transcranial Magnetic Stimulation (TMS) Devices break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.